BMath, BHSc (Comp Med), MMath, MBA
Rice Bran Arabinoxylan Compound and quality of life of cancer patients
Rice bran arabinoxylan compound (RBAC) is a plant-based biological response modifier for enhancing depleted immune system during and after cancer treatment. Current evidence suggests RBAC may potentially improve cancer patients’ quality of life (QoL).
This research proposes to conduct a pilot feasibility trial to evaluate the effects of RBAC on cancer patients’ QoL, compared to placebo, using a validated questionnaire. Other outcome measures include body mass index and inflammatory-nutritional index. and cytokines profile. The study intends to measure changes in the cytokines profile and to explore the potential effects of RBAC on the gut microbiota of cancer patients compared to placebo.
Read more about a current clinical trial of Rice Bran Arabinoxylan Compound (RBAC) and quality of life of cancer patients.
Daiwa Pharmaceutical Co., Ltd., Japan